Research Article

The Prevalence and Risk Factors of Gastric Polyp in Asymptomatic Patients Receiving Health Examination

Table 2

Univariate analysis of the risk factors of gastric polyp development ().

Principal parameterG polyps (−)G polyps (+) value

Sex, n (%)0.117
 Men230 (68.2)87 (60.8)
 Women107 (31.8)56 (39.2)
Age (yr.), n (%)0.315
 <4573 (21.7)37 (25.9)
 >45264 (78.3)106 (74.1)
Age (yr.), n (%)0.016
 Between 45–60155 (46.0)81 (57.0)
 Not between 45–60182 (54.0)62 (43.0)
Education (yr.), n (%)0.318
 Middle school33 (9.8)20 (14.0)
 High school90 (26.7)31 (21.7)
 University164 (48.7)75 (52.4)
 Graduate school50 (14.8)17 (11.9)
BMI, n (%)0.577
 <25225 (66.8)89 (62.2)
 25–30100 (29.7)47 (32.9)
 >3012 (3.6)7 (4.9)
Waist circumference (%)0.990
 <80 cm109 (32.3)45 (31.7)
 80–90 cm153 (45.4)65 (45.8)
 >90 cm75 (22.3)332 (22.5)
NSAID use, n (%)0.788
 No324 (96.1)139 (97.2)
 Yes13 (3.9)4 (2.8)
Family history of gastric cancer, n (%)0.523
 No327 (97.0)141 (98.6)
 Yes10 (3.0)2 (1.4)
Smoking status, n (%)0.009
 Never smoking204 (60.5)68 (47.3)
 Former smoking53 (15.7)22 (15.4)
 Current smoking80 (23.7)53 (37.3)
Alcohol drinking, n (%)0.725
 No214 (63.7)96 (67.1)
 ≤3 times per week99 (29.5)37 (25.9)
 >3 times per week23 (6.8)10 (7.0)
Coffee drinking, n (%)0.358
 No107 (31.8)55 (38.5)
 ≤3 times per week73 (21.7)27 (18.9)
 >3 times per week157 (46.6)61 (42.7)
Tea drinking, n (%)0.688
 No125 (37.1)56 (39.2)
 ≤3 times per week78 (23.1)28 (19.6)
 >3 times per week134 (39.8)59 (41.3)
Spicy food consumption, n (%)0.223
 No181 (53.7)90 (62.9)
 ≤3 times per week94 (27.9)32 (22.4)
 >3 times per week62 (18.4)21 (14.7)
Betel nut use, n (%)0.186
 No330 (98.2)141 (99)
 Yes6 (1.8)2 (1.0)
Exercise habit, n (%)0.045
 No129 (38.3)68 (47.3)
 ≤3 times per week119 (35.3)49 (34.2)
 >3 times per week89 (26.4)26 (18.5)
Vegetarian, n (%)0.233
 No319 (97.3)139 (97.9)
 Yes9 (2.7)4 (2.1)
Helicobacter pylori, n (%)0.218
 Not done53 (15.9)25 (17.5)
 (−)215 (63.7)92 (64.3)
 (+)69 (23.4)26 (18.2)

BMI = body mass index; NSAID = nonsteroidal anti-inflammatory drug. .